Search hospitals > Alabama > Birmingham
Children's Hospital of Alabama
Claim this profileBirmingham, Alabama 35233
Global Leader in Tumors
Global Leader in Recurrence
Conducts research for Leukemia
Conducts research for Lymphoma
Conducts research for Brain Tumor
302 reported clinical trials
27 medical researchers
Summary
Children's Hospital of Alabama is a medical facility located in Birmingham, Alabama. This center is recognized for care of Tumors, Recurrence, Leukemia, Lymphoma, Brain Tumor and other specialties. Children's Hospital of Alabama is involved with conducting 302 clinical trials across 512 conditions. There are 27 research doctors associated with this hospital, such as Matthew A. Kutny, Gregory Friedman, MD, Girish Dhall, MD, and Waldemar A Carlo, MD.Area of expertise
1Tumors
Global LeaderStage IV
Stage I
Stage II
2Recurrence
Global LeaderStage IV
Stage I
Stage II
Top PIs
Matthew A. KutnyChildren's Hospital of Alabama4 years of reported clinical research
Expert in Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
36 reported clinical trials
82 drugs studied
Gregory Friedman, MDChildren's Hospital of Alabama8 years of reported clinical research
Studies Tumors
Studies Recurrence
19 reported clinical trials
32 drugs studied
Girish Dhall, MDChildren's Hospital of Alabama2 years of reported clinical research
Studies Brain Tumor
Studies Recurrence
17 reported clinical trials
36 drugs studied
Waldemar A Carlo, MDUniversity of Alabama at Birmingham5 years of reported clinical research
Studies Premature Infants
Studies Premature Birth
15 reported clinical trials
21 drugs studied
Clinical Trials running at Children's Hospital of Alabama
Brain Tumor
Osteosarcoma
Non-Hodgkin's Lymphoma
Langerhans Cell Histiocytosis
Germ Cell Tumors
Tumors
Acute Myeloid Leukemia
Lymphoma
Recurrence
Solid Tumors
DAY101 vs. Chemotherapy
for Pediatric Brain Cancer
This trial is testing tovorafenib, a medication given alone, in children with a specific type of brain tumor. The drug works by blocking a protein that helps cancer cells grow.
Recruiting2 awards Phase 3
Selumetinib vs Carboplatin/Vincristine
for Brain Cancer
This phase III trial studies if selumetinib works just as well as the standard treatment with carboplatin/vincristine (CV) for subjects with NF1-associated low grade glioma (LGG), and to see if selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and vincristine.
Recruiting2 awards Phase 328 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Children's Hospital of Alabama?
Children's Hospital of Alabama is a medical facility located in Birmingham, Alabama. This center is recognized for care of Tumors, Recurrence, Leukemia, Lymphoma, Brain Tumor and other specialties. Children's Hospital of Alabama is involved with conducting 302 clinical trials across 512 conditions. There are 27 research doctors associated with this hospital, such as Matthew A. Kutny, Gregory Friedman, MD, Girish Dhall, MD, and Waldemar A Carlo, MD.